Nikolaos Kokkorakis, Marios Zouridakis, & Maria Gaitanou. (2024). Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy. MDPI AG.
Chicago Style (17th ed.) CitationNikolaos Kokkorakis, Marios Zouridakis, and Maria Gaitanou. Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy. MDPI AG, 2024.
MLA (9th ed.) CitationNikolaos Kokkorakis, et al. Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy. MDPI AG, 2024.
Warning: These citations may not always be 100% accurate.